>
Switch to:

NovoCure EV-to-Revenue

: 34.61 (As of Today)
View and export this data going back to 2015. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, NovoCure's enterprise value is $18,246.8 Mil. NovoCure's Revenue for the trailing twelve months (TTM) ended in Mar. 2021 was $527.2 Mil. Therefore, NovoCure's EV-to-Revenue for today is 34.61.

NAS:NVCR' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.96   Med: 16.76   Max: 62.74
Current: 34.61

4.96
62.74

During the past 8 years, the highest EV-to-Revenue of NovoCure was 62.74. The lowest was 4.96. And the median was 16.76.

NAS:NVCR's EV-to-Revenue is ranked lower than
84% of the 674 Companies
in the Medical Devices & Instruments industry.

( Industry Median: 5.96 vs. NAS:NVCR: 34.61 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2021-05-15), NovoCure's stock price is $179.27. NovoCure's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2021 was $4.91. Therefore, NovoCure's PS Ratio for today is 36.55.


NovoCure EV-to-Revenue Historical Data

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovoCure Annual Data
Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only 6.76 9.73 12.20 23.41 35.01

NovoCure Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.35 14.20 24.69 35.01 25.32

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


NovoCure EV-to-Revenue Distribution

* The bar in red indicates where NovoCure's EV-to-Revenue falls into.



NovoCure EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

NovoCure's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=18246.804/527.233
=34.61

NovoCure's current Enterprise Value is $18,246.8 Mil.
NovoCure's Revenue for the trailing twelve months (TTM) ended in Mar. 2021 was 115.925 (Jun. 2020 ) + 132.66 (Sep. 2020 ) + 143.953 (Dec. 2020 ) + 134.695 (Mar. 2021 ) = $527.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NovoCure  (NAS:NVCR) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

NovoCure's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=179.27/4.905
=36.55

NovoCure's share price for today is $179.27.
NovoCure's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2021 was 1.077 (Jun. 2020 ) + 1.221 (Sep. 2020 ) + 1.295 (Dec. 2020 ) + 1.312 (Mar. 2021 ) = $4.91.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NovoCure EV-to-Revenue Related Terms


NovoCure EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)